Gould-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
215
Total Value
143132512
Accession Number
0001908965-25-000003
Form Type
13F-HR
Manager Name
Gould-Capital
Data Enrichment
83% identified
178 identified37 unidentified

Holdings

215 positions • $143.1M total value
Manager:
Search and click to pin securities to the top
Page 11 of 11
464287762
Shares:12
Value:$731
% of Portfolio:0.0% ($731/$143.1M)
Adeia Inc.
Shares:50
Value:$661
% of Portfolio:0.0% ($661/$143.1M)
Spotify Technology S.A.
Shares:1
Value:$550
% of Portfolio:0.0% ($550/$143.1M)
464288885
Shares:5
Value:$500
% of Portfolio:0.0% ($500/$143.1M)
Emergent BioSolutions Inc.
Shares:100
Value:$486
% of Portfolio:0.0% ($486/$143.1M)
BIOGEN INC.
Shares:3
Value:$411
% of Portfolio:0.0% ($411/$143.1M)
ImmunityBio, Inc.
Shares:117
Value:$352
% of Portfolio:0.0% ($352/$143.1M)
Crocs, Inc.
Shares:3
Value:$319
% of Portfolio:0.0% ($319/$143.1M)
GE Vernova Inc.
Shares:1
Value:$305
% of Portfolio:0.0% ($305/$143.1M)
NORDSTROM INC
Shares:10
Value:$245
% of Portfolio:0.0% ($245/$143.1M)
Lucid Group, Inc.
Shares:80
Value:$194
% of Portfolio:0.0% ($194/$143.1M)
GE HealthCare Technologies Inc.
Shares:2
Value:$161
% of Portfolio:0.0% ($161/$143.1M)
294628102
Shares:75
Value:$121
% of Portfolio:0.0% ($121/$143.1M)
BP PRUDHOE BAY ROYALTY TRUST
Shares:70
Value:$39
% of Portfolio:0.0% ($39/$143.1M)
Eaton Vance Tax-Advantaged Global Dividend Income Fund
Shares:0
Value:$0
% of Portfolio:0.0% ($0/$143.1M)